Osteoporosis is a major confounder in observational studies investigating bisphosphonate therapyin aortic stenosis

Journal of the American College of Cardiology

Volumn 60, Issue 11, 2012, Pages 1027-

  Dweck, Marc R ^a   Newby, David E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

AORTA STENOSIS; CALCIFICATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; HUMAN; LETTER; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AORTIC VALVE; AORTIC VALVE STENOSIS; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; DIPHOSPHONATES; FEMALE; HUMANS;

EID: 84865762097     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.048     Document Type: Letter

References (4)

1. O. Aksoy, A. Cam, S.S. Goel Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol 59 2012 1452 1459
2. Y. Aksoy, C. Yagmur, G.O. Tekin Aortic valve calcification: association with bone mineral density and cardiovascular risk factors Coron Artery Dis 16 2005 379 383
3. V. Persy, P. D'Haese Vascular calcification and bone disease: the calcification paradox Trends Mol Med 15 2009 405 416
4. P. Raggi, C. Giachelli, A. Bellasi Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis Nat Clin Pract Cardiovasc Med 4 2007 26 33